Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

EHTHeHealth, Inc.

Nasdaq · CIK 0001333493
Filer categoryAccelerated filer<br>Smaller reporting company
Entity typeoperating
SIC6411 Insurance Agents, Brokers & Service
FY end1231
XBRL facts490

Identity from submissions API

NameeHealth, Inc.
CIK0001333493
TickersEHTH
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer<br>Smaller reporting company
SIC6411 Insurance Agents, Brokers & Service
EIN562357876
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone737-248-2340
Website—
Investor website—
Owner org02 Finance
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
9190 PRIORITY WAY WEST DR., SUITE 110
INDIANAPOLIS
IN
46240
IN
Mailing address
9190 PRIORITY WAY WEST DR., SUITE 110
INDIANAPOLIS
IN
46240
IN

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1786 filing rows loaded from submissions recent; extra archives: CIK0001333493-submissions-001.json (786 filings, 2006-04-25 to 2015-01-18).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000234 005-82333 261544977 34 8868
2026-11-05 10-Q 10-Q 0001333493-26-000045 001-33071 261523896 34 9595409 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001333493-26-000044 001-33071 261522548 34 3458100 1 1
2026-10-16 8-K 8-K 3.01 0001333493-26-000040 001-33071 261466170 34 143001 1 1
2026-10-13 4 FORM 4 0001950061-26-000021 4860
2026-10-13 4 FORM 4 0002005261-26-000023 4866
2026-10-13 4 FORM 4 0001931967-26-000025 4852
2026-10-02 4 FORM 4 0001233184-26-000019 7335
2026-10-02 144 xsl144X01/primary_doc.xml 0001950047-26-009994 001-33071 261436229 33 6957
2026-10-01 144 xsl144X01/primary_doc.xml 0001950047-26-009925 001-33071 261431428 33 6242
2026-09-11 4 FORM 4 0002005261-26-000021 4867
2026-09-11 4 FORM 4 0001931967-26-000023 4853
2026-09-03 4 FORM 4 0002005261-26-000019 5191
2026-09-03 4 FORM 4 0001931967-26-000021 5177
2026-09-03 4 FORM 4 0001950061-26-000019 5185
2026-09-02 4 FORM 4 0001233184-26-000015 7330
2026-09-01 144 xsl144X01/primary_doc.xml 0001950047-26-008915 001-33071 261351138 33 5519
2026-08-31 144 xsl144X01/primary_doc.xml 0001950047-26-008871 001-33071 261347205 33 4796
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000185 005-82333 261270849 34 8813
2026-08-05 4 FORM 4 0001499498-26-000006 4850
2026-08-05 S-8 S-8 0001333493-26-000038 333-298017 261244142 33 237611 1 1
2026-08-05 10-Q 10-Q 0001333493-26-000036 001-33071 261243983 34 9672976 1 1
2026-08-04 8-K 8-K 2.02,9.01 0001333493-26-000033 001-33071 261239089 34 3336422 1 1
2026-07-28 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002480 005-82333 261212504 34 10779
2026-07-14 4 FORM 4 0001931967-26-000019 4852
2026-07-14 4 FORM 4 0001950061-26-000017 4860
2026-07-14 4 FORM 4 0002005261-26-000017 4866
2026-06-25 8-K 8-K 5.02,5.07,9.01 0001333493-26-000029 001-33071 261122036 34 344761 1 1
2026-06-23 4 FORM 4 0001793004-26-000008 16252
2026-06-23 4 FORM 4 0001228861-26-000006 6366
2026-06-23 4 FORM 4 0001233184-26-000011 5605
2026-06-23 4 FORM 4 0001488754-26-000008 5539
2026-06-23 4 FORM 4 0001786769-26-000009 5574
2026-06-23 4 FORM 4 0001509185-26-000002 5522
2026-06-23 4 FORM 4 0001398116-26-000002 16267
2026-06-12 4 FORM 4 0001950061-26-000015 5067
2026-06-12 4 FORM 4 0002005261-26-000015 4867
2026-05-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000090 005-82333 26977209 34 8691
2026-05-12 4 FORM 4 0001931967-26-000017 4852
2026-05-07 10-Q 10-Q 0001333493-26-000027 001-33071 26949974 34 8127011 1 1
2026-05-06 8-K 8-K 2.02,5.02,9.01 0001333493-26-000025 001-33071 26948734 34 3355075 1 1
2026-04-28 ARS ARS 0001140361-26-017457 001-33071 26908301 34 7738110
2026-04-28 4 FORM 4 0002005261-26-000013 4866
2026-04-28 4 FORM 4 0001950061-26-000013 4860
2026-04-28 4 FORM 4 0001931967-26-000015 4852
2026-04-28 DEFA14A DEFA14A 0001333493-26-000021 001-33071 26908085 34 362040
2026-04-28 DEF 14A DEF 14A 0001333493-26-000020 001-33071 26908044 34 3334736 1 1
2026-04-14 4 FORM 4 0002005261-26-000011 4865
2026-04-14 4 FORM 4 0001950061-26-000011 4860
2026-04-14 4 FORM 4 0001931967-26-000013 4852
2026-04-10 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001999371-26-008111 005-82333 26854998 34 24248
2026-03-31 8-K 8-K 5.02,9.01 0001333493-26-000014 001-33071 26822712 34 308072 1 1
2026-03-20 4 FORM 4 0001931967-26-000011 5203
2026-03-20 4 FORM 4 0001950061-26-000009 5191
2026-03-20 4 FORM 4 0002005261-26-000009 5197
2026-03-20 4 FORM 4 0001233184-26-000003 5094
2026-03-12 4 FORM 4 0001950061-26-000007 4723
2026-03-12 4 FORM 4 0002005261-26-000007 4729
2026-03-09 4 FORM 4 0001931967-26-000009 5110
2026-03-02 4 FORM 4 0001499498-26-000004 4557
2026-02-26 10-K 10-K 0001333493-26-000010 001-33071 26688226 34 12152677 1 1
2026-02-25 8-K 8-K 2.02,9.01 0001333493-26-000007 001-33071 26678978 34 3642264 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001999371-26-003586 005-82333 26645018 34 39028
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002073679-26-000031 005-82333 26642348 34 162800
2026-02-12 4 FORM 4 0001931967-26-000004 4670
2026-01-13 4 FORM 4 0002005261-26-000002 4663
2026-01-13 4 FORM 4 0001931967-26-000002 4666
2026-01-13 4 FORM 4 0001950061-26-000002 4657
2026-01-06 8-K 8-K 1.01,1.02,2.03,3.03,5.03,7.01,9.01 0001333493-26-000003 001-33071 26509513 34 1852821 1 1
2025-12-18 8-K 8-K 5.03,7.01,9.01 0001333493-25-000115 001-33071 251581409 34 412010 1 1
2025-12-11 4 FORM 4 0001950061-25-000011 4874
2025-12-11 4 FORM 4 0002005261-25-000009 4669
2025-12-11 4 FORM 4 0001931967-25-000014 4672
2025-12-04 UPLOAD filename1.pdf 0000000000-25-011284 001-33071 39474
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112664 005-82333 251487479 34 10625
2025-11-12 4 FORM 4 0001931967-25-000012 4671
2025-11-06 10-Q 10-Q 0001333493-25-000111 001-33071 251455361 34 9289278 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001333493-25-000110 001-33071 251454376 34 3100549 1 1
2025-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000122 005-82333 251434629 34 6231
2025-10-14 4 FORM 4 0002005261-25-000007 4667
2025-10-14 4 FORM 4 0001931967-25-000010 4670
2025-10-14 4 FORM 4 0001950061-25-000009 4661
2025-10-07 8-K 8-K 1.01,2.03,7.01,9.01 0001333493-25-000106 001-33071 251380340 34 372838 1 1
2025-10-07 CORRESP filename1.htm 0001333493-25-000103 30379
2025-09-24 4 FORM 4 0001233184-25-000005 15283
2025-09-24 UPLOAD filename1.pdf 0000000000-25-010425 001-33071 43794
2025-09-19 4 FORM 4 0001509185-25-000006 5007
2025-09-19 3 FORM 3 0001509185-25-000004 14260
2025-09-19 3 FORM 3 0001499498-25-000006 14888
2025-09-19 8-K 8-K 5.02 0001333493-25-000101 001-33071 251326984 34 141134 1 1
2025-09-12 4 FORM 4 0002005261-25-000005 4668
2025-09-12 4 FORM 4 0001950061-25-000007 4662
2025-09-12 4 FORM 4 0001931967-25-000008 4671
2025-08-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002646 333-289376 251226188 33 1716
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000769993-25-000504 005-82333 251215856 34 17054
2025-08-13 CORRESP filename1.htm 0001333493-25-000099 144747
2025-08-12 4 FORM 4 0001931967-25-000006 4671
2025-08-12 UPLOAD filename1.pdf 0000000000-25-008462 333-289376 40037
2025-08-07 S-3 S-3 0001333493-25-000097 333-289376 251194905 33 1269904 1 1
2025-08-07 S-8 S-8 0001333493-25-000095 333-289366 251194559 33 237283 1 1
2025-08-07 10-Q 10-Q 0001333493-25-000094 001-33071 251194450 34 9189621 1 1
2025-08-06 8-K 8-K 2.02,9.01 0001333493-25-000087 001-33071 251187479 34 3366565 1 1
2025-08-05 4 FORM 4 0001333493-25-000085 20543
2025-07-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000852 005-82333 251159798 34 6125
2025-07-29 8-K 8-K 5.02,7.01,9.01 0001333493-25-000083 001-33071 251157998 34 524415 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003024 005-82333 251132181 34 10671
2025-07-14 4 FORM 4 0002005261-25-000003 4667
2025-07-14 4 FORM 4 0001931967-25-000004 4670
2025-07-14 4 FORM 4 0001950061-25-000005 4661
2025-06-24 4 FORM 4 0001333493-25-000080 4648
2025-06-24 8-K 8-K 5.02,5.07,9.01 0001333493-25-000078 001-33071 251069218 34 398139 1 1
2025-06-20 4 FORM 4 0001333493-25-000076 5331
2025-06-20 4 FORM 4 0001762644-25-000003 5403
2025-06-20 4 FORM 4 0001333493-25-000074 5396
2025-06-20 4 FORM 4 0001488754-25-000003 5354
2025-06-20 4 FORM 4 0001861238-25-000003 5400
2025-06-20 4 FORM 4 0001333493-25-000072 6064
2025-06-20 4 FORM 4 0001333493-25-000070 21667
2025-06-12 4 FORM 4 0001333493-25-000067 4668
2025-06-12 4 FORM 4 0001950061-25-000003 4662
2025-06-02 DEFA14A DEFA14A 0001333493-25-000065 001-33071 251015214 34 110773
2025-05-30 4 FORM 4 0001333493-25-000063 5057
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001999371-25-006233 005-82333 25954662 34 33513
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049558 005-82333 25954661 34 10808
2025-05-13 4 FORM 4 0001333493-25-000059 4670
2025-05-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000769993-25-000236 005-82333 25929222 34 16413
2025-05-07 10-Q 10-Q 0001333493-25-000057 001-33071 25921891 34 8041012 1 1
2025-05-07 8-K 8-K 2.02,9.01 0001333493-25-000054 001-33071 25919299 34 3629898 1 1
2025-05-06 4 FORM 4 0001333493-25-000051 4649
2025-04-28 ARS ARS 0001140361-25-016031 001-33071 25880631 34 1186638
2025-04-28 DEFA14A DEFA14A 0001333493-25-000049 001-33071 25880365 34 290464
2025-04-28 DEF 14A DEF 14A 0001333493-25-000047 001-33071 25880213 34 2940555 1 1
2025-04-11 4 FORM 4 0001333493-25-000041 6484
2025-04-11 4 FORM 4 0001333493-25-000039 6489
2025-04-11 4 FORM 4 0001333493-25-000037 6493
2025-04-11 4 FORM 4 0001333493-25-000035 4651
2025-03-25 4 FORM 4 0001333493-25-000033 4650
2025-03-12 4 FORM 4 0001333493-25-000031 4674
2025-03-12 4 FORM 4 0001333493-25-000029 4668
2025-02-27 10-K 10-K 0001333493-25-000027 001-33071 25680835 34 11665907 1 1
2025-02-26 8-K 8-K 2.02,9.01 0001333493-25-000023 001-33071 25666168 34 3540551 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001839882-25-009236 005-82333 25628676 34 22680
2025-02-12 4 FORM 4 0001333493-25-000020 4677
2025-02-04 4 FORM 4 0001333493-25-000018 4656
2025-01-14 4 FORM 4 0001333493-25-000016 4673
2025-01-14 4 FORM 4 0001333493-25-000014 4676
2025-01-14 4 FORM 4 0001333493-25-000012 4667
2025-01-14 4 FORM 4 0001333493-25-000010 4657
2025-01-02 4 FORM 4 0001333493-25-000008 4677
2025-01-02 4 FORM 4 0001333493-25-000006 4674
2025-01-02 4 FORM 4 0001333493-25-000004 4668
2025-01-02 4 FORM 4 0001333493-25-000002 4658
2024-12-23 4 FORM 4 0001333493-24-000187 4658
2024-12-17 8-K 8-K 7.01,9.01 0001333493-24-000185 001-33071 241553706 34 287248 1 1
2024-12-12 4 FORM 4 0001333493-24-000183 6759
2024-12-12 4 FORM 4 0001333493-24-000181 6753
2024-12-12 4 FORM 4 0001333493-24-000179 5248
2024-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-119146 005-82333 241463800 34 10644
2024-11-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-24-002709 005-82333 241462642 34 131748
2024-11-13 4 FORM 4 0001333493-24-000177 7064
2024-11-12 4 FORM 4 0001333493-24-000175 4678
2024-11-12 SC 13G/A UnitedStates_13G__eHealthInc.txt 0000932471-24-000933 005-82333 241446922 34 6501
2024-11-08 144 xsl144X01/primary_doc.xml 0001965301-24-000142 001-33071 241438861 33 4649
2024-11-06 10-Q 10-Q 0001333493-24-000173 001-33071 241431434 34 9172441 1 1
2024-11-06 8-K 8-K 2.02,9.01 0001333493-24-000170 001-33071 241429260 34 3969189 1 1
2024-11-05 4 FORM 4 0001333493-24-000167 4657
2024-11-04 SC 13G/A UnitedStates_13G__eHealthInc.txt 0000932471-24-000430 005-82333 241421701 34 5585
2024-11-01 8-K 8-K 1.01,2.03,9.01 0001333493-24-000165 001-33071 241419417 34 1521343 1 1
2024-10-15 4 FORM 4 0001333493-24-000163 4674
2024-10-15 4 FORM 4 0001333493-24-000161 4668
2024-10-15 4 FORM 4 0001333493-24-000159 4659
2024-10-11 4 FORM 4 0001333493-24-000157 6504
2024-10-09 8-K 8-K 5.02,9.01 0001333493-24-000155 001-33071 241363094 34 155019 1 1
2024-09-26 4 FORM 4 0001333493-24-000153 5008
2024-09-26 3 FORM 3 0001333493-24-000151 12399
2024-09-24 8-K 8-K 5.02,7.01,9.01 0001333493-24-000149 001-33071 241320564 34 279366 1 1
2024-09-24 4 FORM 4 0001333493-24-000147 4658
2024-09-12 4 FORM 4 0001333493-24-000145 4669
2024-09-12 4 FORM 4 0001333493-24-000143 4675
2024-08-22 4 FORM 4 0001333493-24-000141 5064
2024-08-13 4 FORM 4 0001333493-24-000139 4678
2024-08-13 4 FORM 4 0001333493-24-000137 4665
2024-08-08 4 FORM 4 0001333493-24-000135 5163
2024-08-08 4 FORM 4 0001333493-24-000134 5065
2024-08-08 4 FORM 4 0001333493-24-000133 5061
2024-08-08 4 FORM 4 0001333493-24-000132 5054
2024-08-07 S-8 S-8 0001333493-24-000127 333-281336 241184356 33 397750
2024-08-07 10-Q 10-Q 0001333493-24-000126 001-33071 241183997 34 8986280 1 1
2024-08-07 8-K 8-K 2.02,5.02,7.01,9.01 0001333493-24-000122 001-33071 241181469 34 4557048 1 1
2024-08-06 4 FORM 4 0001333493-24-000118 4657
2024-07-12 4 FORM 4 0001333493-24-000116 4674
2024-07-12 4 FORM 4 0001333493-24-000114 4668
2024-07-12 4 FORM 4 0001333493-24-000112 4677
2024-07-12 4 FORM 4 0001333493-24-000110 4659
2024-07-08 SC 13G/A us28238p1093_070824.txt 0001086364-24-008181 005-82333 241105190 34 12849
2024-06-25 4 FORM 4 0001333493-24-000108 4658
2024-06-14 8-K 8-K 5.02,5.07,9.01 0001333493-24-000106 001-33071 241045145 34 483242 1 1
2024-06-13 4 FORM 4 0001333493-24-000104 6060
2024-06-13 4 FORM 4 0001333493-24-000102 5395
2024-06-13 4 FORM 4 0001333493-24-000100 5363
2024-06-13 4 FORM 4 0001333493-24-000098 5391
2024-06-13 4 FORM 4 0001333493-24-000096 5681
2024-06-13 4 FORM 4 0001333493-24-000094 5702
2024-06-12 4 FORM 4 0001333493-24-000092 4675
2024-06-12 4 FORM 4 0001333493-24-000090 4875
2024-06-10 DEFA14A DEFA14A 0001333493-24-000087 001-33071 241031948 34 21942
2024-05-30 8-K 8-K 5.02,7.01,9.01 0001333493-24-000085 001-33071 241005815 34 312325 1 1
2024-05-23 DEFA14A DEFA14A 0001333493-24-000082 001-33071 24975291 34 344453
2024-05-14 4 FORM 4 0001333493-24-000078 4677
2024-05-14 4 FORM 4 0001333493-24-000076 4664
2024-05-07 10-Q 10-Q 0001333493-24-000074 001-33071 24921911 34 7798030 1 1
2024-05-07 8-K 8-K 2.02,9.01 0001333493-24-000072 001-33071 24919631 34 3549239 1 1
2024-05-06 4 FORM 4 0001333493-24-000069 4656
2024-04-26 ARS ARS 0001140361-24-022463 001-33071 24884069 34 1399242
2024-04-26 DEFA14A DEFA14A 0001333493-24-000067 001-33071 24883762 34 300919
2024-04-26 DEF 14A DEF 14A 0001333493-24-000066 001-33071 24883602 34 3797740 1 1
2024-04-12 4 FORM 4 0001333493-24-000062 4658
2024-04-12 4 FORM 4 0001333493-24-000060 4673
2024-04-12 4 FORM 4 0001333493-24-000058 4677
2024-04-12 4 FORM 4 0001333493-24-000056 4667
2024-04-09 4 FORM 4 0001333493-24-000054 4987
2024-04-09 4 FORM 4 0001333493-24-000052 4967
2024-04-09 4 FORM 4 0001333493-24-000050 4977
2024-04-09 4 FORM 4 0001333493-24-000048 4973
2024-03-26 4 FORM 4 0001333493-24-000046 4657
2024-03-15 4 FORM 4 0001333493-24-000044 5020
2024-03-15 4 FORM 4 0001333493-24-000042 5012
2024-03-15 4 FORM 4 0001333493-24-000040 5017
2024-03-15 4 FORM 4 0001333493-24-000038 5002
2024-03-12 4 FORM 4 0001333493-24-000036 4674
2024-03-12 4 FORM 4 0001333493-24-000034 4879
2024-02-29 10-K 10-K 0001333493-24-000032 001-33071 24704168 34 12959754 1 1
2024-02-27 8-K 8-K 2.02,9.01 0001333493-24-000029 001-33071 24682011 34 3254406 1 1
2024-02-14 SC 13G/A AMENDMENT NO. 1 0001999371-24-002361 005-82333 24640739 34 88525
2024-02-14 SC 13G/A ehealth.htm 0001306923-24-000005 005-82333 24639887 34 11714
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-020820 005-82333 24628434 34 12961
2024-02-13 4 FORM 4 0001333493-24-000026 4677
2024-02-13 4 FORM 4 0001333493-24-000024 4664
2024-02-07 SC 13G/A Ehealth.txt 0000769993-24-000078 005-82333 24606105 34 23643
2024-02-06 4 FORM 4 0001333493-24-000022 4656
2024-02-02 4 FORM 4 0001333493-24-000020 4665
2024-01-26 8-K 8-K 2.02,9.01 0001333493-24-000018 001-33071 24564259 34 309821 1 1
2024-01-25 SC 13G/A EHTH_SC13GA2.htm 0001319244-24-000013 005-82333 24562314 34 85331
2024-01-24 SC 13G/A us28238p1093_012424.txt 0001086364-24-002683 005-82333 24557838 34 13372
2024-01-12 4 FORM 4 0001333493-24-000015 4652
2024-01-12 4 FORM 4 0001333493-24-000013 4661
2024-01-12 4 FORM 4 0001333493-24-000011 4670
2024-01-12 4 FORM 4 0001333493-24-000009 4667
2024-01-04 4 FORM 4 0001333493-24-000007 5025
2024-01-04 3 FORM 3 0001333493-24-000005 13428
2024-01-03 4 FORM 4 0001333493-24-000003 4652
2023-12-27 4 FORM 4 0001333493-23-000155 4664
2023-12-19 SC 13G SCHEDULE 13G 0000921895-23-002778 005-82333 231497328 34 139144
2023-12-12 4 FORM 4 0001333493-23-000153 4599
2023-12-12 4 FORM 4 0001333493-23-000151 4626
2023-11-20 8-K 8-K 5.02,7.01,9.01 0001333493-23-000149 001-33071 231422980 34 316054 1 1
2023-11-14 4 FORM 4 0001333493-23-000145 4596
2023-11-14 4 FORM 4 0001333493-23-000143 4608
2023-11-09 10-Q 10-Q 0001333493-23-000141 001-33071 231389450 34 8885907 1 1
2023-11-08 8-K 8-K 2.02,9.01 0001333493-23-000140 001-33071 231388216 34 3155896 1 1
2023-11-06 4 FORM 4 0001333493-23-000134 4587
2023-10-12 4 FORM 4 0001333493-23-000132 4589
2023-10-12 4 FORM 4 0001333493-23-000129 4626
2023-10-12 4 FORM 4 0001333493-23-000127 4598
2023-10-12 4 FORM 4 0001333493-23-000125 4607
2023-09-26 4 FORM 4 0001333493-23-000123 4588
2023-09-19 4 FORM 4 0001333493-23-000121 5614
2023-09-12 4 FORM 4 0001333493-23-000119 4599
2023-09-12 4 FORM 4 0001333493-23-000117 4626
2023-08-14 4 FORM 4 0001333493-23-000115 4608
2023-08-08 10-Q 10-Q 0001333493-23-000113 001-33071 231151742 34 8834117 1 1
2023-08-08 8-K 8-K 2.02,9.01 0001333493-23-000110 001-33071 231149367 34 2425555 1 1
2023-08-04 4 FORM 4 0001333493-23-000107 4587
2023-07-12 4 FORM 4 0001333493-23-000105 4598
2023-07-12 4 FORM 4 0001333493-23-000103 4626
2023-07-12 4 FORM 4 0001333493-23-000101 4607
2023-07-12 4 FORM 4 0001333493-23-000099 4589
2023-07-10 SC 13D/A SC 13D/A 0001193125-23-184655 005-82333 231080104 34 149778
2023-06-26 4 FORM 4 0001333493-23-000097 4588
2023-06-21 8-K 8-K 5.07 0001333493-23-000095 001-33071 231030033 34 168370 1 1
2023-06-16 4 FORM 4 0001333493-23-000093 4992
2023-06-16 4 FORM 4 0001333493-23-000091 5962
2023-06-16 4 FORM 4 0001333493-23-000089 5266
2023-06-16 4 FORM 4 0001333493-23-000087 11050
2023-06-16 4 FORM 4 0001333493-23-000085 5298
2023-06-16 4 FORM 4 0001333493-23-000083 5294
2023-06-16 4 FORM 4 0001333493-23-000081 11368
2023-06-12 4 FORM 4 0001333493-23-000073 4599
2023-06-12 4 FORM 4 0001333493-23-000071 4626
2023-06-01 4 FORM 4 0001333493-23-000069 7412
2023-06-01 4 FORM 4 0001333493-23-000067 4993
2023-05-12 4 FORM 4 0001333493-23-000065 4648
2023-05-09 10-Q 10-Q 0001333493-23-000063 001-33071 23902762 34 7951174 1 1
2023-05-09 8-K 8-K 2.02,9.01 0001333493-23-000060 001-33071 23900015 34 2191415 1 1
2023-05-04 4 FORM 4 0001333493-23-000057 4627
2023-05-01 ARS ARS 0001140361-23-021896 001-33071 23870645 34 3850763
2023-05-01 DEFA14A NOTICE & ACCESS 0001333493-23-000055 001-33071 23870338 34 1280748
2023-05-01 DEF 14A DEF 14A 0001333493-23-000053 001-33071 23870315 34 4081692 1 1
2023-05-01 8-K 8-K 7.01,9.01 0001333493-23-000051 001-33071 23870279 34 287362 1 1
2023-04-12 4 FORM 4 0001333493-23-000034 4953
2023-04-12 4 FORM 4 0001333493-23-000032 4980
2023-04-12 4 FORM 4 0001333493-23-000030 4964
2023-04-12 4 FORM 4 0001333493-23-000028 6456
2023-03-24 4 FORM 4 0001333493-23-000026 4628
2023-03-17 4 FORM 4 0001333493-23-000024 7475
2023-03-17 4 FORM 4 0001333493-23-000022 4942
2023-03-14 4 FORM 4 0001333493-23-000020 4633
2023-03-01 10-K 10-K 0001333493-23-000018 001-33071 23695155 34 13923388 1 1
2023-02-28 8-K 8-K 2.02,9.01 0001333493-23-000012 001-33071 23678409 34 2861410 1 1
2023-02-14 SC 13G/A ehealthv6.txt 0001306923-23-000003 005-82333 23629587 34 275374
2023-02-14 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-23-002054 005-82333 23629207 34 136711
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015843 005-82333 23602977 34 12922
2023-02-08 8-K 8-K 5.02,9.01 0001333493-23-000010 001-33071 23599516 34 226523 1 1
2023-02-07 SC 13G EHEALTH_INC.txt 0000769993-23-000077 005-82333 23595522 34 23430
2023-02-06 SC 13G/A us28238p1093_020623.txt 0001306550-23-007863 005-82333 23589514 34 13204
2023-02-03 4 FORM 4 0001333493-23-000008 4592
2023-02-02 SC 13G sc13gehealth.htm 0001426859-23-000001 005-82333 23580640 34 62741
2023-01-24 8-K 8-K 2.02,9.01 0001333493-23-000006 001-33071 23548699 34 232128 1 1
2023-01-12 4 FORM 4 0001333493-23-000004 4597
2023-01-09 SC 13G/A EHTH_SC13GA_2023.htm 0001273087-23-000008 005-82333 23518554 34 85275
2023-01-04 4 FORM 4 0001333493-23-000002 7700
2022-12-23 4 FORM 4 0001333493-22-000158 4597
2022-12-19 8-K 8-K 5.03,9.01 0001333493-22-000156 001-33071 221471393 34 365400 1 1
2022-12-05 4 FORM 4 0001333493-22-000154 4914
2022-11-25 4 FORM 4 0001333493-22-000152 4993
2022-11-21 4 FORM 4 0001333493-22-000150 5680
2022-11-18 3 FORM 3 0001333493-22-000148 6946
2022-11-16 SC 13G EHTH_SC13G_Nov22.htm 0001273087-22-000117 005-82333 221395479 34 85249
2022-11-15 SC 13D/A AMENDMENT NO. 3 TO THE SCHEDULE 13D 0000921895-22-003053 005-82333 221392138 34 443467
2022-11-14 8-K 8-K 5.02,7.01,9.01 0001333493-22-000146 001-33071 221380691 34 275278 1 1
2022-11-08 S-8 S-8 0001333493-22-000144 333-268253 221369875 33 214192
2022-11-08 10-Q 10-Q 0001333493-22-000143 001-33071 221369839 34 9608345 1 1
2022-11-07 8-K 8-K 2.02,9.01 0001333493-22-000140 001-33071 221365616 34 3161499 1 1
2022-11-04 4 FORM 4 0001333493-22-000138 4596
2022-10-12 4 FORM 4 0001333493-22-000136 4598
2022-10-12 4 FORM 4 0001333493-22-000134 4604
2022-10-11 3 FORM 3 0001333493-22-000132 7641
2022-10-07 SC 13G/A us28238p1093_100622.txt 0000834237-22-010864 005-82333 221300481 34 13211
2022-10-05 8-K 8-K 5.02,9.01 0001333493-22-000130 001-33071 221295730 34 307499 1 1
2022-09-26 SC 13G RIGL_SC13G_Sept22.htm 0001273087-22-000110 005-82333 221266141 34 82017
2022-09-26 4 FORM 4 0001333493-22-000127 4602
2022-09-13 4 FORM 4 0001333493-22-000125 4613
2022-09-07 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-09-07 16:30:00 9999999995-22-002610 333-267048 221232429 33 1690
2022-09-02 CORRESP filename1.htm 0001333493-22-000123 59728
2022-09-02 UPLOAD filename1.pdf 0000000000-22-009552 40027
2022-08-24 S-3 S-3 0001333493-22-000121 333-267048 221192139 33 1027369
2022-08-22 8-K 8-K 1.01,9.01 0001333493-22-000116 001-33071 221184429 34 1775237 1 1
2022-08-09 8-K/A 8-K/A 2.02 0001333493-22-000112 001-33071 221149587 34 197168 1 1
2022-08-09 S-8 S-8 0001333493-22-000110 333-266682 221146022 33 146496
2022-08-09 10-Q 10-Q 0001333493-22-000109 001-33071 221146018 34 14458244 1 1
2022-08-08 8-K 8-K 2.02,5.02,9.01 0001333493-22-000105 001-33071 221144784 34 3865025 1 1
2022-08-04 4 FORM 4 0001333493-22-000097 4601
2022-07-19 4 FORM 4 0001333493-22-000094 4643
2022-07-12 4 FORM 4 0001333493-22-000092 9720
2022-07-12 4 FORM 4 0001333493-22-000090 7915
2022-07-12 4 FORM 4 0001333493-22-000088 7945
2022-07-05 4 FORM 4 0001333493-22-000086 8334
2022-06-21 8-K 8-K 5.02,5.07,9.01 0001333493-22-000084 001-33071 221028319 34 371446 1 1
2022-06-17 4 FORM 4 0001333493-22-000082 8388
2022-06-17 4 FORM 4 0001333493-22-000080 8555
2022-06-17 4 FORM 4 0001333493-22-000078 8348
2022-06-17 4 FORM 4 0001333493-22-000076 9040
2022-06-17 4 FORM 4 0001333493-22-000074 8379
2022-06-17 4 FORM 4 0001333493-22-000072 5126
2022-06-17 4 FORM 4 0001333493-22-000070 5432
2022-06-02 3 FORM 3 0001333493-22-000067 6850
2022-06-02 8-K 8-K 5.02 0001333493-22-000065 001-33071 22991014 34 174416 1 1
2022-05-11 DEFA14A DEFA14A 0001333493-22-000063 001-33071 22913281 34 28799
2022-05-06 10-Q 10-Q 0001333493-22-000061 001-33071 22901769 34 7916968 1 1
2022-05-04 4 FORM 4 0001333493-22-000059 4604
2022-05-03 8-K 8-K 2.02,9.01 0001333493-22-000057 001-33071 22887061 34 3152456 1 1
2022-05-02 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001333493-22-000025,2022-05-02 9999999995-22-001238 333-257571 22884425 33 1702
2022-05-02 DEFA14A NOTICE & ACCESS 0001333493-22-000055 001-33071 22881129 34 1285055
2022-05-02 DEF 14A DEF 14A 0001333493-22-000053 001-33071 22881106 34 2104226
2022-04-19 4 FORM 4 0001333493-22-000051 4647
2022-04-01 4 FORM 4 0001333493-22-000049 4953
2022-04-01 4 FORM 4 0001333493-22-000047 7556
2022-04-01 4 FORM 4 0001333493-22-000045 5048
2022-04-01 4 FORM 4 0001333493-22-000043 7376
2022-04-01 4 FORM 4 0001333493-22-000041 6498
2022-03-25 3 FORM 3 SUBMISSION 0000899243-22-012335 18324
2022-03-22 S-8 S-8 0001333493-22-000039 333-263760 22759546 33 114377
2022-03-18 8-K 8-K 5.02,9.01 0001333493-22-000036 001-33071 22752447 34 273458 1 1
2022-03-15 4 FORM 4 0001333493-22-000034 7457
2022-03-11 SC 13D/A SCHEDULE 13D (AMENDMENT NO. 2) 0000914121-22-002019 005-82333 22733129 34 70233
2022-03-10 3 FORM 3 0001333493-22-000032 6927
2022-03-07 4 FORM 4 0001333493-22-000030 4491
2022-03-02 8-K/A 8-K/A 2.02,9.01 0001333493-22-000028 001-33071 22701438 34 3975959 1 1
2022-03-02 POS AM POS AM 0001333493-22-000025 333-257571 22699986 33 468044
2022-03-01 10-K 10-K 0001333493-22-000023 001-33071 22699172 34 14488197 1 1
2022-03-01 8-K 8-K 2.02,9.01 0001333493-22-000021 001-33071 22694039 34 3919083 1 1
2022-03-01 POSASR POSASR 0001333493-22-000019 333-257571 22693334 33 475826
2022-02-28 8-K 8-K 1.01,1.02,2.03,9.01 0001333493-22-000016 001-33071 22690684 34 1605243 1 1
2022-02-28 8-K 8-K 5.02,9.01 0001333493-22-000013 001-33071 22690057 34 239100 1 1
2022-02-14 SC 13G/A ehealthv4.txt 0001306923-22-000005 005-82333 22634069 34 11680
2022-02-09 3 FORM 3 0001333493-22-000009 6643
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-017032 005-82333 22607005 34 12923
2022-02-04 4 FORM 4 0001333493-22-000007 4603
2022-01-31 8-K 8-K 5.02 0001333493-22-000005 001-33071 22574856 34 166936 1 1
2022-01-28 SC 13G/A us28238p1093_012822.txt 0000834237-22-003274 005-82333 22567328 34 13245

Latest XBRL company facts

One latest value per concept from companyfacts (490 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 32.36M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
dei EntityPublicFloat Entity Public Float USD 126.20M 2025-06-30 2025 FY 10-K 2026-02-26 0001333493-26-000010
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 114,813 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001333493-26-000020
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.21M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001333493-26-000020
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 95.04 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001333493-26-000020
ffd NetFeeAmt NetFeeAmt USD 240.57 2026-08-05 S-8 2026-08-05 0001333493-26-000038
ffd TtlFeeAmt TtlFeeAmt USD 240.57 2026-08-05 S-8 2026-08-05 0001333493-26-000038
ffd TtlOfferingAmt TtlOfferingAmt USD 1.74M 2026-08-05 S-8 2026-08-05 0001333493-26-000038
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-05 S-8 2026-08-05 0001333493-26-000038
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 2.27M 2014-09-30 2014 Q3 10-Q 2014-11-10 0001333493-14-000078
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 591.55M 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 2.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 50,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-13 0001333493-13-000033
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 224,000 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap AccruedIncomeTaxesNoncurrent Accrued Income Taxes, Noncurrent USD 19,000 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.01M 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 537,000 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap AccruedRentCurrent Accrued Rent, Current USD 876,000 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap AccruedRentNoncurrent Accrued Rent, Noncurrent USD 1.08M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap AccruedSalesCommissionCurrentAndNoncurrent Accrued Sales Commission USD 1.09M 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 9.74M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 347,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AcquiredFiniteLivedIntangibleAssetAmount Acquired Finite-lived Intangible Asset, Amount (Deprecated 2013-01-31) USD 13.90M 2013-12-31 2013 FY 10-K 2014-03-12 0001333493-14-000029
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 740.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 47,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.08M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 147,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-09 0001333493-16-000093
us-gaap AdvertisingExpense Advertising Expense USD 153.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AmortizationOfAcquisitionCosts Amortization of Acquisition Costs USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 8.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 303,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap Assets Assets USD 1.11B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AssetsCurrent Assets, Current USD 316.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 82.08M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001333493-19-000188
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 21,000 2021-03-31 2021 Q1 10-Q 2021-05-10 0001333493-21-000069
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2,000 2021-03-31 2021 Q1 10-Q 2021-05-10 0001333493-21-000069
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 86.58M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001333493-26-000036
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax USD 0 2016-09-30 2016 Q3 10-Q 2016-11-08 0001333493-16-000155
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 1.77M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001333493-26-000036
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 1.77M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001333493-26-000036
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 72.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 72.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 86.55M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001333493-26-000036
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 30.82M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 1.29M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001333493-20-000183
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap CapitalizedComputerSoftwareAdditions Capitalized Computer Software, Additions USD 13.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CapitalizedComputerSoftwareAmortization Capitalized Computer Software, Amortization (Deprecated 2016-01-31) USD 900,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization USD 2.77M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001333493-26-000027
us-gaap CapitalizedComputerSoftwareImpairments1 Capitalized Computer Software, Impairments USD 300,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-09 0001333493-23-000141
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 22.30M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CapitalizedComputerSoftwarePeriodIncreaseDecrease Capitalized Computer Software, Period Increase (Decrease) USD -4.34M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-06 0001628280-18-013751
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 112,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap Cash Cash USD 15.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 57.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -21.49M 2017-01-01 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 59.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -16.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 41.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 5.80M 2024-12-31 2024 FY 10-K 2025-02-27 0001333493-25-000027
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 44.80M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 30.99M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CommonStockValue Common Stock, Value, Issued USD 46,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -63.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractualObligation Contractual Obligation USD 9.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 4.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 652,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 4.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss Contract with Customer, Asset, Allowance for Credit Loss USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease Contract with Customer, Asset, Allowance for Credit Loss, Period Increase (Decrease) USD 534,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractWithCustomerAssetAllowanceForCreditLossWriteoff Contract with Customer, Asset, Allowance for Credit Loss, Writeoff USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001333493-24-000173
us-gaap ContractWithCustomerAssetCreditLossExpense Contract with Customer, Asset, Credit Loss Expense (Reversal) USD 534,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 970.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 208.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractWithCustomerAssetNetNoncurrent Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent USD 761.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 10.55M 2021-09-30 2021 Q3 10-Q 2021-11-08 0001333493-21-000167
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap CostOfRevenue Cost of Revenue USD 1.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CostsAndExpenses Costs and Expenses USD 219.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD -1.15M 2020-01-01 2020 Q1 10-Q 2020-05-11 0001333493-20-000076
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 158,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 330,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 172,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 40 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 2.73M 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 13.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 12.00M 2025-12-31 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 264,000 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 18.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -22.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 281.39M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 34.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 385,000 2017-12-31 2017 Q4 10-K 2018-03-19 0001333493-18-000025
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 4.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 21.45M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 229.95M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 160,000 2017-12-31 2017 Q4 10-K 2018-03-19 0001333493-18-000025
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 386,000 2014-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 204,000 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 224.17M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001333493-15-000016
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 176.63M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 1.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 7.80M 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 15.12M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 833,000 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 3.54M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 6.08M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 5.78M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 57.22M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.05M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 45.09M 2017-12-31 2018 Q3 10-Q 2018-11-06 0001628280-18-013751
us-gaap DeferredTaxLiabilitiesOtherFiniteLivedAssets Deferred Tax Liabilities, Other Finite-Lived Assets USD 710,000 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 4.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) pure 0.25 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001333493-14-000029
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.85 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap Depreciation Depreciation USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 12.51M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001333493-24-000173
us-gaap DividendsCash Dividends, Cash USD 5.60M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001333493-25-000027
us-gaap DueToAffiliateNoncurrent Due to Affiliate, Noncurrent USD 1.27M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.56 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001333493-20-000183
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.257 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure -0.027 2017-01-01 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 96,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.074 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001333493-25-000027
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent pure 0.001 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.067 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 1,000 2017-01-01 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 424,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 16.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 58,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards Share-based Payment Arrangement, Cash Used to Settle Award USD -255,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 11.70M 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 2.00M 2022-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 1.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap EntityWideDisclosureOnGeographicAreasLongLivedAssetsInEntitysCountryOfDomicile Disclosure on Geographic Areas, Long-Lived Assets in Entity's Country of Domicile (Deprecated 2013-01-31) USD 37.05M 2013-12-31 2013 FY 10-K 2014-03-12 0001333493-14-000029
us-gaap EntityWideDisclosureOnGeographicAreasLongLivedAssetsInForeignCountries Disclosure on Geographic Areas, Long-Lived Assets in Foreign Countries (Deprecated 2013-01-31) USD 347,000 2013-12-31 2013 FY 10-K 2014-03-12 0001333493-14-000029
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 2.36M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-06 0001333493-12-000075
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 14.28M 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap FiniteLivedIntangibleAssetsAcquired Finite-lived Intangible Assets Acquired (Deprecated 2013-01-31) USD 6.30M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001333493-14-000029
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 13.90M 2010-11-01 2012-06-30 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 1.00M 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months USD 1.04M 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 535,000 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 545,000 2019-09-30 2019 Q3 10-Q 2019-11-08 0001333493-19-000188
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling after Year Five USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five USD 346,000 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four USD 346,000 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three USD 346,000 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two USD 1.04M 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 480,000 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 480,000 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 480,000 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 480,000 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 17.20M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap GainLossOnDispositionOfProperty Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) USD -1,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001333493-13-000033
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -1.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 46.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap Goodwill Goodwill USD 0 2023-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 40.20M 2021-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap GrossProfit Gross Profit USD 29.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap GuarantyLiabilities Guaranty Liabilities USD 700,000 2012-12-31 2012 FY 10-K 2013-03-13 0001333493-13-000033
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 2.92M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 3.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 500,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 57.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -86.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 1.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 3.93M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218755
us-gaap IncomeTaxesPaid Income Taxes Paid USD 441,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001333493-25-000027
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 390,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 51,000 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap IncomeTaxesReceivableNoncurrent Income Taxes Receivable, Noncurrent USD 456,000 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap IncomeTaxExaminationInterestAccrued Income Tax Examination, Interest Accrued USD 300,000 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap IncomeTaxExaminationInterestExpense Income Tax Examination, Interest Expense USD 100,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 2.00M 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -22.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 228,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 162,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 2.30M 2017-01-01 2017-12-31 2017 Q4 10-K 2018-03-19 0001333493-18-000025
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -59,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 12.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 954,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 3.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 528,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -24.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -5.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 653,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -2.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -466,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -24.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 935,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 2.36M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-06 0001333493-12-000075
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 1.28M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218755
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 7.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncreaseInCarryingAmountOfRedeemablePreferredStock Increase in Carrying Amount of Redeemable Preferred Stock USD 14.49M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 326,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-07 0001333493-17-000107
us-gaap IndefinitelivedIntangibleAssetsAcquired Indefinite-lived Intangible Assets Acquired USD 4.80M 2014-03-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 1.92M 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap InsuranceCommissionsAndFees Insurance Commissions and Fees USD 227.21M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 8.00M 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 1.92M 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap InterestExpense Interest Expense USD 2.81M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0001333493-24-000074
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 12.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap InterestIncomeOperating Interest Income, Operating USD 7.20M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001333493-25-000027
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 44,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 8.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 35.20M 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap LeaseCost Lease, Cost USD 647,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 3.45M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 17.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 7.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 196,000 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 196,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 8.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 100,000 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 3.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 800,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LessorOperatingLeasePaymentsToBeReceivedThereafter Lessor, Operating Lease, Payment to be Received, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 3.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 100,000 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap Liabilities Liabilities USD 200.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.11B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LiabilitiesCurrent Liabilities, Current USD 36.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 28.30M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001333493-19-000188
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 3.34M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims Liabilities Subject to Compromise, Provision for Expected and Allowed Claims USD 0 2016-09-30 2016 Q3 10-Q 2016-11-08 0001333493-16-000155
us-gaap LineOfCredit Long-term Line of Credit USD 115.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 115.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 1.20M 2020-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap LossContingencyNewClaimsFiledNumber Loss Contingency, New Claims Filed, Number claim 2 2020-04-08 2020-04-30 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap LossContingencyPendingClaimsNumber Loss Contingency, Pending Claims, Number class_action_lawsuit 2 2015-03-10 2016 Q1 10-Q 2016-05-09 0001333493-16-000093
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 48.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 59.68M 2016-09-30 2016 Q3 10-Q 2016-11-08 0001333493-16-000155
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -3.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -33.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 19.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -64.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -106.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -106.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NoncurrentAssets Long-Lived Assets USD 24.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 21,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218755
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap NumberOfStatesInWhichEntityOperates Number of States in which Entity Operates state 50 2023-06-30 2023 Q2 10-Q 2023-08-08 0001333493-23-000113
us-gaap OperatingExpenses Operating Expenses USD 5.50M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-08 0001333493-16-000155
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -76.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 3.69M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001333493-23-000113
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 7.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 16.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 6.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 9.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OperatingLeasePayments Operating Lease, Payments USD 6.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 38.27M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 8.65M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 3.10M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 3.90M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 4.33M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 7.43M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 10.86M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.43M 2018-09-30 2018 Q3 10-Q 2018-11-06 0001628280-18-013751
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 5.30M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.058 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 370,000 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap OtherAmortizationOfDeferredCharges Amortization of Other Deferred Charges USD 2.00M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 22.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax (Deprecated 2012-01-31) USD -20,000 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-15 0001193125-12-115547
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD -25,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-15 0001193125-12-115547
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 455,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -138,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001333493-23-000113
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 123,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0001333493-23-000063
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 116,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-08 0001333493-16-000155
us-gaap OtherDeferredCostAmortizationExpense Other Deferred Cost, Amortization Expense (Deprecated 2013-01-31) USD 3.10M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001333493-14-000029
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 6.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 4.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 2.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap PaymentsForPurchaseOfOtherAssets Payments for Purchase of Other Assets (Deprecated 2013-01-31) USD 4.37M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218755
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap PaymentsForRestructuring Payments for Restructuring USD 6.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.05M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001333493-25-000027
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 3.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 10.97M 2021-04-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 40.55M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-15 0001193125-12-115547
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 59.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001333493-15-000016
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 673,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PaymentsToDevelopSoftware Payments to Develop Software USD 6.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 79.586 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2021-04-30 2023-06-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2021-04-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 7.75M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap PrepaidAdvertising Prepaid Advertising USD 10.94M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001333493-19-000188
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 485,000 2026-03-31 2026 Q1 10-Q 2026-05-07 0001333493-26-000027
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 9.75M 2024-09-30 2024 Q3 10-Q 2024-11-06 0001333493-24-000173
us-gaap PrepaidExpenseOtherNoncurrent Prepaid Expense Other, Noncurrent USD 18.00M 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap PrepaidInsurance Prepaid Insurance USD 691,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PrepaidRent Prepaid Rent USD 96,000 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD 800,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap ProceedsFromCommissionsReceived Proceeds from Commissions Received USD 280.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 103,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001333493-22-000143
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 122.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 33.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 5.01M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-15 0001193125-12-115547
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 14.27M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 64,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-08 0001333493-16-000155
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 103,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 70.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 13.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap RestrictedCash Restricted Cash USD 1.61M 2019-06-30 2019 Q2 10-Q 2019-08-08 0001628280-19-010326
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 2.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 6.25M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 1.86M 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated employee 339 2022-01-01 2022-06-30 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.14 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap RestructuringCharges Restructuring Charges USD 6.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 6.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap RestructuringReserve Restructuring Reserve USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap RestructuringReserveAccrualAdjustment Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) USD 297,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD -297,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 700,000 2026-03-31 2026 Q1 10-Q 2026-05-07 0001333493-26-000027
us-gaap RestructuringReserveNoncurrent Restructuring Reserve, Noncurrent USD 78,000 2016-06-30 2016 Q2 10-Q 2016-08-08 0001333493-16-000131
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -47.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 142.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap Revenues Revenues USD 251.40M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 214.03M 2021-04-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 2.25M 2021-04-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 115 2020-03-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap SecurityDeposit Security Deposit USD 555,000 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap SecurityDepositLiability Security Deposit Liability USD 820,000 2018-12-31 2018 FY 10-K 2019-03-14 0001628280-19-002899
us-gaap SelfInsuranceReserve Self Insurance Reserve USD 3.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 500,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 7.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 39.01M 2014-06-30 2014 Q2 10-Q 2014-08-08 0001333493-14-000060
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 1.31M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 74.54 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 2.42M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 47.31 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 2.48M 2022-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 49.56 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 203,000 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-08 0001333493-14-000060
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 53.48 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.641 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.012 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 1.50M 2022-09-01 2022-09-30 2023 Q3 10-Q 2023-11-09 0001333493-23-000141
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 2.10M 2024-12-31 2024 FY 10-K 2025-02-27 0001333493-25-000027
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 40.09M 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.16M 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16.29 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 22,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 17.9 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.00M 2021-09-22 2023-09-30 2023 Q3 10-Q 2023-11-09 0001333493-23-000141
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.46 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 8,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 60.22M 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 226,000 2022-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 18.01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 58.19M 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.77M 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 17.86 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 3.30M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001333493-14-000029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.24M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 16.63 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 28.82 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-12 0001333493-14-000029
us-gaap SharePrice Share Price USD/shares 18.99 2018-01-22 2020 FY 10-K 2021-02-26 0001333493-21-000019
us-gaap ShortTermBorrowings Short-term Debt USD 69.09M 2025-06-30 2025 Q2 10-Q 2025-08-07 0001333493-25-000094
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 493.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 137,000 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-09 0001333493-14-000043
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 28.52M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 102,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 228.02M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0001333493-23-000018
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 347,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-15 0001193125-12-115547
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 0 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 1.01M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-08 0001333493-16-000155
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 50.00M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap StockRepurchaseProgramAuthorizedAmount Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) USD 50.00M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001333493-14-000078
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 50.00M 2014-03-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap SubleaseIncome Sublease Income USD 2.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 500,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap TemporaryEquityAccretionOfDividends Temporary Equity, Accretion of Dividends USD 14.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 23.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 23.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 419.18M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 18.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 2.25M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 2.25M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 36.91 2014-07-01 2014-07-31 2016 FY 10-K 2017-03-16 0001333493-17-000021
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 13.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap TreasuryStockNumberOfSharesHeld Treasury Stock, Number of Shares Held (Deprecated 2016-01-31) shares 11.12M 2016-09-30 2016 Q3 10-Q 2016-11-08 0001333493-16-000155
us-gaap TreasuryStockShares Treasury Stock, Shares shares 12.50M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001333493-23-000063
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001333493-23-000141
us-gaap TreasuryStockValue Treasury Stock, Value USD 200.00M 2022-03-31 2022 Q1 10-Q 2022-05-06 0001333493-22-000061
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 1.10M 2019-12-31 2019 FY 10-K 2020-03-02 0001333493-20-000021
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 11.69M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 243,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 862,000 2017-01-01 2017-12-31 8-K 2018-12-17 0001628280-18-015182
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 100,000 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 938,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001333493-24-000032
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001333493-16-000078
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 100,000 2021-12-31 2021 FY 10-K 2022-03-01 0001333493-22-000023
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD -2.00M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001333493-17-000138
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 139,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 6.60M 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 654,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001333493-26-000010
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-07 0001628280-18-010716
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 31.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 25.84M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001333493-20-000183
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 21.02M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-07 0001333493-13-000068
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 31.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001333493-26-000045
us-gaap WeightedAverageNumberOfSharesTreasuryStock Weighted Average Number of Shares, Treasury Stock shares 1.26M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-07 0001333493-13-000068

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →